Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors

P. Molnár, D. Groothuis, R. Blasberg, D. Zaharko, E. Owens, J. Fenstermacher

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The regional distribution and local incorporation of [14C]thymidine into a nonextractable tissue fraction, probably DNA, was measured in normal and neoplastic tissues. We studied brain tumors induced by avian sarcoma virus and ethylnitrosourea, and transplanted RG-2 intracerebral and subcutaneous gliomas. An incorporation quotient, Q, was calculated for different tumor regions and brain from the methanol nonextractable radioactivity in the tissue and the plasma concentration-time integral of thymidine. The incorporation quotient represents the rate of clearance of thymidine from blood and its incorporation into macromolecules (probably DNA). The values of Q were compared with a labeling index measured in the same tissue regions with conventional autoradiography. The following observations were made: (1) the mean plasma half-life of thymidine was 6.5 min; (2) the regional incorporation quotient in tumors varied from values comparable to normal brain to more than 100 times higher; (3) RG-2 tumors had significantly higher Qs than the other tumor models; (4) Q in subcutaneous tumors varied most widely (>500-fold range); (5) the labeling index reflected the values of Q in some tumor regions but not in others; differences between the two were most frequently related to tumor cell density and the intensity of individual tumor cell labeling. A comparison of these data with previous studies of capillary permeability and blood flow in these tumor models indicates that the incorporation of [14C]thymidine into a non-extractable tissue fraction can be limited by transcapillary transport in brain tumors and by blood flow in systemic tumors, and that thymidine disposition in these tumors is not always indicative of the rate of DNA synthesis.

Original languageEnglish
Pages (from-to)421-432
Number of pages12
JournalJournal of Neurochemistry
Volume43
Issue number2
Publication statusPublished - 1984

Fingerprint

Brain Neoplasms
Thymidine
Tumors
Brain
Neoplasms
Tissue
Labeling
Blood
DNA
Avian Sarcoma Viruses
Ethylnitrosourea
Cells
Capillary Permeability
Plasmas
Autoradiography
Glioma
Radioactivity
Methanol
Half-Life
Cell Count

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Molnár, P., Groothuis, D., Blasberg, R., Zaharko, D., Owens, E., & Fenstermacher, J. (1984). Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. Journal of Neurochemistry, 43(2), 421-432.

Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. / Molnár, P.; Groothuis, D.; Blasberg, R.; Zaharko, D.; Owens, E.; Fenstermacher, J.

In: Journal of Neurochemistry, Vol. 43, No. 2, 1984, p. 421-432.

Research output: Contribution to journalArticle

Molnár, P, Groothuis, D, Blasberg, R, Zaharko, D, Owens, E & Fenstermacher, J 1984, 'Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors', Journal of Neurochemistry, vol. 43, no. 2, pp. 421-432.
Molnár P, Groothuis D, Blasberg R, Zaharko D, Owens E, Fenstermacher J. Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. Journal of Neurochemistry. 1984;43(2):421-432.
Molnár, P. ; Groothuis, D. ; Blasberg, R. ; Zaharko, D. ; Owens, E. ; Fenstermacher, J. / Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. In: Journal of Neurochemistry. 1984 ; Vol. 43, No. 2. pp. 421-432.
@article{26d290e2f6cf4cc8b0a581ace8fc2c93,
title = "Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors",
abstract = "The regional distribution and local incorporation of [14C]thymidine into a nonextractable tissue fraction, probably DNA, was measured in normal and neoplastic tissues. We studied brain tumors induced by avian sarcoma virus and ethylnitrosourea, and transplanted RG-2 intracerebral and subcutaneous gliomas. An incorporation quotient, Q, was calculated for different tumor regions and brain from the methanol nonextractable radioactivity in the tissue and the plasma concentration-time integral of thymidine. The incorporation quotient represents the rate of clearance of thymidine from blood and its incorporation into macromolecules (probably DNA). The values of Q were compared with a labeling index measured in the same tissue regions with conventional autoradiography. The following observations were made: (1) the mean plasma half-life of thymidine was 6.5 min; (2) the regional incorporation quotient in tumors varied from values comparable to normal brain to more than 100 times higher; (3) RG-2 tumors had significantly higher Qs than the other tumor models; (4) Q in subcutaneous tumors varied most widely (>500-fold range); (5) the labeling index reflected the values of Q in some tumor regions but not in others; differences between the two were most frequently related to tumor cell density and the intensity of individual tumor cell labeling. A comparison of these data with previous studies of capillary permeability and blood flow in these tumor models indicates that the incorporation of [14C]thymidine into a non-extractable tissue fraction can be limited by transcapillary transport in brain tumors and by blood flow in systemic tumors, and that thymidine disposition in these tumors is not always indicative of the rate of DNA synthesis.",
author = "P. Moln{\'a}r and D. Groothuis and R. Blasberg and D. Zaharko and E. Owens and J. Fenstermacher",
year = "1984",
language = "English",
volume = "43",
pages = "421--432",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors

AU - Molnár, P.

AU - Groothuis, D.

AU - Blasberg, R.

AU - Zaharko, D.

AU - Owens, E.

AU - Fenstermacher, J.

PY - 1984

Y1 - 1984

N2 - The regional distribution and local incorporation of [14C]thymidine into a nonextractable tissue fraction, probably DNA, was measured in normal and neoplastic tissues. We studied brain tumors induced by avian sarcoma virus and ethylnitrosourea, and transplanted RG-2 intracerebral and subcutaneous gliomas. An incorporation quotient, Q, was calculated for different tumor regions and brain from the methanol nonextractable radioactivity in the tissue and the plasma concentration-time integral of thymidine. The incorporation quotient represents the rate of clearance of thymidine from blood and its incorporation into macromolecules (probably DNA). The values of Q were compared with a labeling index measured in the same tissue regions with conventional autoradiography. The following observations were made: (1) the mean plasma half-life of thymidine was 6.5 min; (2) the regional incorporation quotient in tumors varied from values comparable to normal brain to more than 100 times higher; (3) RG-2 tumors had significantly higher Qs than the other tumor models; (4) Q in subcutaneous tumors varied most widely (>500-fold range); (5) the labeling index reflected the values of Q in some tumor regions but not in others; differences between the two were most frequently related to tumor cell density and the intensity of individual tumor cell labeling. A comparison of these data with previous studies of capillary permeability and blood flow in these tumor models indicates that the incorporation of [14C]thymidine into a non-extractable tissue fraction can be limited by transcapillary transport in brain tumors and by blood flow in systemic tumors, and that thymidine disposition in these tumors is not always indicative of the rate of DNA synthesis.

AB - The regional distribution and local incorporation of [14C]thymidine into a nonextractable tissue fraction, probably DNA, was measured in normal and neoplastic tissues. We studied brain tumors induced by avian sarcoma virus and ethylnitrosourea, and transplanted RG-2 intracerebral and subcutaneous gliomas. An incorporation quotient, Q, was calculated for different tumor regions and brain from the methanol nonextractable radioactivity in the tissue and the plasma concentration-time integral of thymidine. The incorporation quotient represents the rate of clearance of thymidine from blood and its incorporation into macromolecules (probably DNA). The values of Q were compared with a labeling index measured in the same tissue regions with conventional autoradiography. The following observations were made: (1) the mean plasma half-life of thymidine was 6.5 min; (2) the regional incorporation quotient in tumors varied from values comparable to normal brain to more than 100 times higher; (3) RG-2 tumors had significantly higher Qs than the other tumor models; (4) Q in subcutaneous tumors varied most widely (>500-fold range); (5) the labeling index reflected the values of Q in some tumor regions but not in others; differences between the two were most frequently related to tumor cell density and the intensity of individual tumor cell labeling. A comparison of these data with previous studies of capillary permeability and blood flow in these tumor models indicates that the incorporation of [14C]thymidine into a non-extractable tissue fraction can be limited by transcapillary transport in brain tumors and by blood flow in systemic tumors, and that thymidine disposition in these tumors is not always indicative of the rate of DNA synthesis.

UR - http://www.scopus.com/inward/record.url?scp=0021270831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021270831&partnerID=8YFLogxK

M3 - Article

C2 - 6736959

AN - SCOPUS:0021270831

VL - 43

SP - 421

EP - 432

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -